Source: MarketScreener

Soligenix: Soligenix to Present at the BIO Investor Forum

(marketscreener.com) PRINCETON, N.J., Oct. 8, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its President and Chief Executive Officer, Christopher J. Schaber, Ph.D., will deliver a corporate...https://www.marketscreener.com/news/latest/Soligenix-to-Present-at-the-BIO-Investor-Forum--31506135/?utm_medium=RSS&utm_content=20201008

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Christopher J. Schaber's photo - Chairman & CEO of Soligenix

Chairman & CEO

Christopher J. Schaber

CEO Approval Rating

88/100

Soligenix is a late-stage biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases. Read more